Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 1
2006 1
2007 1
2008 1
2011 2
2012 1
2014 3
2015 4
2016 5
2017 3
2018 3
2019 2
2020 3
2021 7
2022 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "FNCLCC Sarcoma Grade 3"
Page 1
Prediction of Histologic Subtype and FNCLCC Grade by SUVmax Measured on (18)F-FDG PET/CT in Patients with Retroperitoneal Liposarcoma.
Li CP, Liu DN, Zhou NN, Tian XY, Wang Z, Liu BN, Hao CY. Li CP, et al. Contrast Media Mol Imaging. 2021 Jan 6;2021:7191363. doi: 10.1155/2021/7191363. eCollection 2021. Contrast Media Mol Imaging. 2021. PMID: 33505228 Free PMC article.
The median SUVmax for FNCLCC Grades 1, 2, and 3 of RPLS was 2.5 (IQR: 1.9-3.2), 4.5 (IQR: 3.2-6.7), and 9.0 (IQR: 6.0-13.3). The ROC curves suggest that SUVmax of 3.8 and >5.3 can be used for predicting FNCLCC G …
The median SUVmax for FNCLCC Grades 1, 2, and 3 of RPLS was 2.5 (IQR: 1.9-3.2), 4.5 (IQR: 3.2-6.7), and 9 …
Role of the Immunohistochemical ZEB1 Expression in Uterine Mesenchymal Neoplasms.
Çelik M, Çelik ZE. Çelik M, et al. Int J Surg Pathol. 2022 Aug;30(5):520-527. doi: 10.1177/10668969211070180. Epub 2022 Jan 7. Int J Surg Pathol. 2022. PMID: 34994578
We studied a series of 69 uterine mesenchymal neoplasms including 18 endometrial stromal sarcomas (10 cases of low grade and 8 cases of high grade endometrial stromal sarcomas), 26 leiomyosarcomas (8 cases of grade 1 and 19 cases of grade …
We studied a series of 69 uterine mesenchymal neoplasms including 18 endometrial stromal sarcomas (10 cases of low grade and 8 …
Giant leiomyosarcoma of the transverse colon.
Nguyen C, Athigaman M, Qureshi A. Nguyen C, et al. BMJ Case Rep. 2021 Dec 2;14(12):e246646. doi: 10.1136/bcr-2021-246646. BMJ Case Rep. 2021. PMID: 34857593 Free PMC article.
Microscopically, the tumour was found to invade the muscularis propria layer of the transverse colon. The final diagnosis was LMS, FNCLCC grade 2 of 3 based on the histology and immunochemistry....
Microscopically, the tumour was found to invade the muscularis propria layer of the transverse colon. The final diagnosis was LMS, FNCLCC …
Relationship between magnetic resonance imaging findings and histological grade in spinal peripheral nerve sheath tumors in dogs.
Morabito S, Specchi S, Di Donato P, Pollard D, Dennis R, De Risio L, Bacon NJ, Potamopoulou M, Rupp S, Corlazzoli D, Ribeiro J, Cozzi F, Jurina K, Cappello R, Mercuriali E, Beckmann K, Flegel T, Menchetti M, König F, Matiasek K, Rosati M. Morabito S, et al. J Vet Intern Med. 2023 Nov-Dec;37(6):2278-2290. doi: 10.1111/jvim.16839. Epub 2023 Sep 19. J Vet Intern Med. 2023. PMID: 37726924 Free PMC article.
METHODS: A multicenter retrospective study including cases with (a) histopathologic diagnosis of PNST and (b) MRI studies available for review. Histologic slides were reviewed and graded by a board-certified pathologist according to a modified French system (FNCLCC) …
METHODS: A multicenter retrospective study including cases with (a) histopathologic diagnosis of PNST and (b) MRI studies available for revi …
Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult-soft tissue sarcomas. An international collaborative study.
Machado I, Cruz J, Righi A, Gambarotti M, Ferrari C, Ruengwanichayakun P, Giner F, Rausell N, Lavernia J, Sugita S, Najera L, Suarez L, Sanjuan X, García JAN, García Del Muro FJ, Gómez-Mateo MC, Valladares MM, Ramos-Oliver I, Romagosa C, Parafioriti A, Elisabetta A, di Bernardo A, Navarro S, Hasegawa T, Arana E, Llombart-Bosch A. Machado I, et al. Pathol Res Pract. 2021 Sep;225:153562. doi: 10.1016/j.prp.2021.153562. Epub 2021 Jul 22. Pathol Res Pract. 2021. PMID: 34329836
The CB grading matched the final FNCLCC grading (low vs high) in 175 (87.9%) of the 199 resected tumors; overestimating the final grade in three cases and underestimating in 21 cases. ...Our study confirms that classifying grade 1 as low grad …
The CB grading matched the final FNCLCC grading (low vs high) in 175 (87.9%) of the 199 resected tumors; overestimating …
Primary Synovial Sarcoma of the Bone: A Case Report and Literature Review.
Ichikawa J, Kawasaki T, Imada H, Kanno S, Ookita G, Taniguchi N, Ashizawa T, Tatsuno R, Jyubashi T, Haro H. Ichikawa J, et al. Anticancer Res. 2023 Sep;43(9):4241-4247. doi: 10.21873/anticanres.16617. Anticancer Res. 2023. PMID: 37648290 Review.
BACKGROUND/AIM: Synovial sarcoma (SS), a spindle cell sarcoma, typically occurs in the soft tissues of the extremities and rarely develops in the bones as a primary tumor. ...Immunohistochemistry (IHC) showed positive staining for SS18:SSX and SSX, and fluorescence …
BACKGROUND/AIM: Synovial sarcoma (SS), a spindle cell sarcoma, typically occurs in the soft tissues of the extremities and rar …
Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors.
Nishida Y, Urakawa H, Nakayama R, Kobayashi E, Ozaki T, Ae K, Matsumoto Y, Tsuchiya H, Goto T, Hiraga H, Naka N, Takahashi S, Ando Y, Ando M, Kuwatsuka Y, Hamada S, Ueda T, Kawai A. Nishida Y, et al. Int J Cancer. 2021 Jan 1;148(1):140-149. doi: 10.1002/ijc.33201. Epub 2020 Aug 3. Int J Cancer. 2021. PMID: 32638374 Free article. Clinical Trial.
The study enrolled 12 patients. Median age was 49 years. Seven had Grade 2 and five Grade 3 according to the FNCLCC evaluation. Median follow-up period was 10.6 months. ...Of special interest, the median PFS was 2.9 months for patients with FNCLCC …
The study enrolled 12 patients. Median age was 49 years. Seven had Grade 2 and five Grade 3 according to the FNCLCC …
Myxofibrosarcoma in adolescents and young adults: a clinicopathologic study of 17 cases.
Arispe Angulo KR, Logan S, Bahrami A, John I, Billings SD, Agrawal S, Bena J, Mesko N, Folpe AL, Fritchie KJ. Arispe Angulo KR, et al. Hum Pathol. 2023 Dec;142:90-95. doi: 10.1016/j.humpath.2023.09.005. Epub 2023 Sep 22. Hum Pathol. 2023. PMID: 37742946
Myxofibrosarcoma is a locally aggressive sarcoma that characteristically arises in the extremities of older patients. ...In untreated resection specimens, 6 were FNCLCC grade 1, 4 grade 2, and 2 grade 3. Follow-up (6-204 months, median 36 …
Myxofibrosarcoma is a locally aggressive sarcoma that characteristically arises in the extremities of older patients. ...In untreated …
Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005).
Brennan B, Zanetti I, Orbach D, Gallego S, Francotte N, Van Noesel M, Kelsey A, Casanova M, De Salvo GL, Bisogno G, Ferrari A. Brennan B, et al. Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26942. Epub 2017 Dec 29. Pediatr Blood Cancer. 2018. PMID: 29286582 Clinical Trial.
BACKGROUND: As alveolar soft part sarcomas (ASPS) are rare with no prospective series within pediatric sarcoma trials, the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) examined the clinical data and outcomes of ASPS enrolled in a multinational …
BACKGROUND: As alveolar soft part sarcomas (ASPS) are rare with no prospective series within pediatric sarcoma trials, the Eur …
How long should we follow patients with soft tissue sarcomas?
Sawamura C, Matsumoto S, Shimoji T, Okawa A, Ae K. Sawamura C, et al. Clin Orthop Relat Res. 2014 Mar;472(3):842-8. doi: 10.1007/s11999-013-3076-6. Clin Orthop Relat Res. 2014. PMID: 23716116 Free PMC article.
BACKGROUND: Guidelines suggest that followup for low-grade soft tissue sarcomas should be every 3 to 6 months for 2 to 3 years and then annually, and for high-grade sarcomas every 3 to 6 months for 2 to 5 years, then every 6 months …
BACKGROUND: Guidelines suggest that followup for low-grade soft tissue sarcomas should be every 3 to 6 months for 2 to …
39 results